For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...

For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation in the digestive tract and the absence of a dedicated intestinal transport ...

Researchers from Kumamoto University have developed a new peptide-based technology that enables insulin—normally injected—to be taken orally while still powerfully lowering blood sugar. Their ...

Psychologists and technologists see them as the future of therapy. The Food and Drug Administration is exploring whether to regulate them as medical devices. Psychologists and technologists see them ...

As more young people identify as transgender, a fight has re-emerged over therapy that questions their gender identities. By Amy Harmon Since at least a decade ago, a rare consensus has prevailed on a ...

The US Supreme Court heard a case Tuesday that will determine whether a Colorado law that prohibits licensed mental health professionals from providing conversion “therapy” to minors is constitutional ...

YAVNE, Israel, September 25, 2025-- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that Australia’s Therapeutic Goods ...

(RTTNews) - Israeli biotechnology company MediWound Ltd. (MDWD) announced that Australia's Therapeutic Goods Administration (TGA) has granted marketing authorization for NexoBrid, the Company's ...

MediWound Expands Global Reach with Marketing Approval of NexoBrid ® in Australia TGA Approves NexoBrid ® for Adults and Children; Manufacturing Readiness Positions MediWound for 2025 Launch and ...

Good day, and welcome to MediWound Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Dan ...